Table 1 Comparisons of baseline data between NPWT group and Non-NPWT group [(\(\overline x\)± s), n (%), M (P25,P75)]
Variables | NPWT | Non-NPWT | P-value |
|---|---|---|---|
Number of patients | 40 | 20 | |
Gender male, % | 24 (60.0%) | 12 (60.0%) | 1.000 |
Age, year | 53.9 ± 10.8 | 52.3 ± 11.5 | 0.682 |
Diabetes duration, year | 11.3 ± 5.2 | 10.9 ± 4.9 | 0.584 |
Ulcer duration, week | 7.8 ± 1.8 | 7.9 ± 1.7 | 0.705 |
ULA, cm2 | 10.6 ± 3.1 | 10.4 ± 2.9 | 0.827 |
FPG, mmol/L | 11.1 ± 2.9 | 10.9 ± 3.1 | 0.419 |
Wagner grade (II/III) | 13/27 | 8/12 | 0.566 |
HbA1c, % | 9.1 ± 2.6 | 8.8 ± 2.1 | 0.389 |
ABI | 1.07 ± 0.13 | 1.12 ± 0.14 | 0.428 |
CRP, mg/dl | 39.2 ± 12.4 | 38.8 ± 11.6 | 0.691 |
WBC, ×109 | 11.2 ± 4.4 | 10.3 ± 3.9 | 0.714 |
ESR, mm/h | 39.7 ± 16.5 | 40.1 ± 17.3 | 0.682 |
Hb, g/L | 114 ± 16 | 116 ± 15 | 0.624 |
Alb, g/L | 39.1 ± 3.5 | 38.7 ± 3.3 | 0.695 |
T-IL-1β, pg/ml | 15.7 ± 7.2 | 14.2 ± 6.9 | 0.417 |
T-IL-6, pg/ml | 80.3 ± 16.6 | 78.1 ± 17.9 | 0.371 |
T-IL-4, pg/ml | 4.9 ± 1.5 | 5.1 ± 1.8 | 0.603 |
T-IL-10, pg/ml | 5.3 ± 2.7 | 5.7 ± 2.5 | 0.486 |
T-miR-155 | 6.83 (2.15–15.72) | 7.15 (2.52–19.07) | 0.398 |
T-FGF7 | 0.504 ± 0.119 | 0.491 ± 0.122 | 0.527 |
